You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VSL3

Showing 1 - 25 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long COVID Trial in Milan (VSL#3®, Placebo)

Recruiting
  • Long COVID
  • VSL#3®
  • Placebo
  • Milan, MI, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
May 22, 2023

Type 1 Diabetes Trial in MIlan (Probiotic Vivomixx®, Placebo)

Recruiting
  • Type 1 Diabetes
  • Probiotic Vivomixx®
  • Placebo
  • MIlan, Italy
    Autoimmune Pathogenesis Unit
Mar 10, 2023

Environmental Enteric Dysfunction, Stunting Trial in Matiari (Vivomixx, CapScan®)

Not yet recruiting
  • Environmental Enteric Dysfunction
  • Stunting
  • Matiari, Sindh, Pakistan
    Mother and Child Health Research and Training Center
Jun 20, 2023

the Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in Man Trial in Gothenburg (VSL#3, Placebo)

Completed
  • the Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in Man
  • VSL#3
  • Placebo
  • Gothenburg, Sweden
    Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital
Oct 14, 2021

Type1diabetes, Type1 Diabetes Trial in Milwaukee (VSL#3)

Completed
  • Type1diabetes
  • Type1 Diabetes Mellitus
  • VSL#3
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Nov 28, 2021

Asthma Trial in Baltimore (VSL#3, VSL#3 or )

Terminated
Has Results
  • Asthma
  • VSL#3
  • VSL#3 or placebo
  • Baltimore, Maryland
    University of Maryland Baltimore
Jun 29, 2021

Fibromyalgia, Gastrointestinal Disease Trial in Granada (VSL#3, Placebo)

Completed
Has Results
  • Fibromyalgia
  • Gastrointestinal Disease
  • VSL#3
  • Placebo
  • Granada, Spain
    Instituto de Neurociencias "Federico Oloriz"
Jul 12, 2021

Environmental Enteric Dysfunction, Probiotic Trial in Guédiawaye (VSL#3, CapsCan, Placebo)

Not yet recruiting
  • Environmental Enteric Dysfunction
  • Probiotic
  • Guédiawaye, Dakar, Senegal
    Centre de santé de Wakhinane
Aug 11, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Munich, Mainz, Münster (Vivomixx®, Conjugated linoleic acid (CLA/Tonalin® FFA

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Vivomixx®
  • +3 more
  • Munich, Bavaria, Germany
  • +2 more
Jun 15, 2023

Environmental Enteropathy Trial in Worldwide (dietary supplement, device, combination product)

Not yet recruiting
  • Environmental Enteropathy
  • VSL#3
  • +2 more
  • Dhaka, Bangladesh
  • +3 more
Nov 1, 2022

Alcohol Use Disorder, Alcoholic Liver Disease, Microbiome Trial in Los Angeles (VSL #3 112.5 Capsule, Placebo)

Recruiting
  • Alcohol Use Disorder
  • +2 more
  • VSL #3 112.5 Capsule
  • Placebo
  • Los Angeles, California
    University of California, Los Angeles
May 16, 2022

Juvenile Idiopathic Arthritis Trial in Paris (VSL#3, Placebo)

Active, not recruiting
  • Juvenile Idiopathic Arthritis
  • VSL#3
  • Placebo
  • Paris, France
    Robert Debre Hospital
Dec 6, 2021

eHealth, Dietary Modification, Probiotics Trial in Frederikssund (Low FODMAP diet (LFD), VSL#3®)

Unknown status
  • eHealth
  • +4 more
  • Low FODMAP diet (LFD)
  • VSL#3®
  • Frederikssund, Capital Region, Denmark
    North Zealand university hospital, Gastro unit
Oct 15, 2020

Cirrhosis Trial in New Delhi (Carvedilol+VSL#3, Endoscopic variceal ligation)

Completed
  • Cirrhosis
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences (ILBS)
May 14, 2020

Oral Lichen Planus Trial in London (Poly-biotic)

Completed
  • Oral Lichen Planus
  • Poly-biotic
  • London, United Kingdom
    University College of London Hospital
Mar 25, 2020

Menopausal Osteoporosis Trial in Atlanta (VSL#3, Placebo)

Terminated
Has Results
  • Menopausal Osteoporosis
  • Atlanta, Georgia
    Emory University Hospital Clinical Research Network, Emory Clini
Mar 2, 2020

Ulcerative Colitis Trial in Roma (VSL#3®, Mesalamine, Placebo)

Terminated
  • Ulcerative Colitis
  • VSL#3®
  • +2 more
  • Roma, Italy
    Istituto di Medicina Interna CIC Columbus Policlinico Universita
Jan 14, 2020

Probiotics Trial in Palo Alto (Omeprazole, VSL #3, Placebo)

Completed
Has Results
  • Probiotics
  • Palo Alto, California
    Stanford University
Feb 27, 2020

Non-Alcoholic Fatty Liver Disease, Probiotics MeSH Descriptor Data 2018, Interleukin-17 MeSH Descriptor Data 2018 Trial in

Terminated
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Probiotic Formulation VSL#3
  • Manhasset, New York
    Northwell Health
Jan 3, 2020

Hypertension, Microbiota Trial in Bologna (exercise training, Probiotics, Placebo)

Recruiting
  • Hypertension
  • Microbiota
  • exercise training
  • +2 more
  • Bologna, Italy
    University of Bologna
Jul 21, 2023

IBS Trial in Boston (VSL#3)

Terminated
  • IBS
  • Boston, Massachusetts
    BIDMC
Feb 26, 2019

Ulcerative Colitis Trial in Xi'an (a multistrain probiotic product (DSF), Placebo)

Unknown status
  • Ulcerative Colitis
  • a multistrain probiotic product (DSF)
  • Placebo
  • Xi'an, Shaanxi, China
    Xijing Digestive Disease
Sep 10, 2019

Primary Biliary Cholangitis Trial in Worldwide (Obeticholic acid, Bezafibrate 200 MG, OCA Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Obeticholic acid
  • +5 more
  • Bedford Park, Perth, Australia
  • +67 more
Dec 2, 2022

Crohn's Disease Trial in Edmonton (Synbiotic, Digestible Maltodextrin)

Recruiting
  • Crohn's Disease
  • Synbiotic
  • Digestible Maltodextrin
  • Edmonton, Alberta, Canada
  • +4 more
Jan 10, 2023

Ileal Pouch Trial in United States (EXE-346, Placebo)

Not yet recruiting
  • Ileal Pouch
  • EXE-346
  • Placebo
  • Baltimore, Maryland
  • +3 more
Jul 3, 2023